Palette Life Sciences, Inc. et al. vs Incept LLC et al.

Other: Fed Circuit mandate

Other: other court decision

Patent Owner's Amended Notice of Appeal

Order Denying Request for Director Review

Petitioner's Mandatory Change-of-Information Notices

Ex. 3100 Director Review Request

Patent Owner's Request for Review by the Director

Patent Owner's Notice of Appeal

Patent Owner's Updated Mandatory Notice

Patent Owner's Power of Attorney

DECISION Granting Patent Owner's Motion for Pro Hac Vice Admission of Timothy E. Grimsrud

DECISION Granting Patent Owner's Motion to Withdraw and Substitute Counsel

Patent Owner's Updated Exhibit List

Ex. 2035 - Declaration of Timothy E. Grimsrud in Support of Motion for Pro Hac Vice Admission

Patent Owner's Motion for Withdrawal and Substitution of Counsel

Patent Owner's Unopposed Motion for Pro Hac Vice Admission of Timothy E. Grimsrud

EXPUNGED

Petitioner's Mandatory Change-of-Information Notices

Final Written Decision Determining All Challenged Claims Unpatentable 35 U.S.C. sec. 318(a)

IPR2020-00002 Notice of Transcript Corrections

Patent Owner's Updated Power of Attorney

Granting Patent Owner's Motions for Withdrawal and Substitution of Counsel 37 C.F.R. sec. 42.10

Hearing Transcript

Patent Owner's Updated Mandatory Notices

Patent Owner Motion for Withdrawal and Substitution of Counsel

Patent Owner Updated Exhibit List

Ex. 2034 - Patent Owner Demonstratives

Petitioner's Updated Exhibit List

EX1156 - Petitioner's Demonstratives

Reply to Opposition to Motion to Exclude

Patent Owner Opposition to Motion to Exclude Evidence

Order - Setting Oral Argument - 37 CFR 42.70

Petitioner's Motion to Exclude Evidence

Ex. 2029 McDuff Trump University Report

Ex. 2030 Order excluding McDuff Testimony

Ex. 2031 Chen 2018

Ex. 2032 Dicker Transcript

Patent Owner Sur-Reply

Ex. 2028 McDuff Transcript

Ex. 2033 McDuff Transcript IPR2017-01621

Petitioner's Updated Exhibit List

Conference Hearing Transcript Taken November 30, 2020

Petitioner's Updated Exhibit List

Petitioner's Request for Oral Argument

Patent Owner Request for Oral Argument

Notice of Deposition of Zhibin Guan

Notice of Deposition of Adam Dicker, M.D., Ph.D.

Patent Owner's Objections to Reply Evidence

Notice of Deposition of DeForest McDuff

EX1075 - Annunziata (2002)

EX1076 - Bloomberg Markets - Incept LLC

EX1077 - Boston Scientific - Form 10-K 2019

EX1078 - SpaceOAR Hydrogel Brochure

EX1079 - Chao (2019)

EX1080 - Anushree Datta Master¿¿¿s Thesis (2007)

EX1081 - Dexur - MEDRAD PRO-TEKT Endorectal Balloon

EX1082 - Digital Impulse - Augmenix

EX1083 - ECRI SpaceOAR System (Augmenix, Inc.) Hydrogel Spacer for Reducing Exposure during Prostate Cancer Radiation Therapy (2017)

EX1084 - FDAnews Augmenix's SpaceOAR Prostate Treatment Receives FDA Clearance (2015)

EX1085 - FDA Establishment Registration & Device Listing Search for Rectal Balloon

EX1088 - Hamdy (2016)

EX1086 - FDA Product Classification for Rectal Balloon for Prostate Immobilization

EX1087 - Fox Factory v. SRAM, 944 F.3d 1366 (Fed. Cir. 2019)

EX1107 - USPTO - Patent Assignment Cover Sheet

EX1114 - Datla (2014)

EX1116 - Steinleitner II (1992)

EX1117 - W.R. Noyes Profile (ASTRO)

EX1121 - PDR Entry for Phenytoin Injection (2001)

EX1122 - FDA - DuraSeal Spine Sealant System (2009)

EX1124 - Treatment Team Brochure (ASTRO)

EX1125 - Teh (2002)

EX1128 - U.S. Patent 6,413,742 issued July 2, 2002

EX1129 - U.S. Patent 6,388,047 issued May 14, 2002

EX1089 - Prostate Cancer - Treat or Wait (2015)

EX1090 - BioProtect Spacer

EX1091 - HHS Medicare Program - Changes to Hospital Outpatients Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs (2018)

EX1092 - HHS Process and Information Required to Appply or Additional Device Categories (2019)

EX1093 - Deposition Transcript of Jessica Ray October 15, 2020

EX1094 - Lin (2008)

EX1095 - Mok (2014)

EX1096 - OncoLink Endorectal Balloons for Prostate Radiation Therapy

EX1097 - Palette Life Sciences website ¿¿¿About¿¿¿ section

EX1098 - Pinkawa (2015)

EX1099 - QLRAD Homepage

EX1100 - S.J. Im (2007)

EX1101 - Santos (2014)

EX1102 - Trifiletti (2016)

EX1103 - B.D. Smith (2010)

EX1104 - How Does SpaceOAR Hydrogel Work

EX1105 - Tae (2001)

EX1106 - Deposition Transcript of Timothy Showalter October 22, 2020

EX1108 - Declaration of DeForest McDuff

EX1109 - Expert Declaration of Dr. Adam Dicker

EX1110 - Expert Declaration of Dr. Zhibin Guan

EX1111 - Deposition Transcript of Gary Wnek October 29, 2020

EX1112 - Curriculum Vitae of Dr. Zhibin Guan

EX1113 - BrachyFoam

EX1115 - Steinleitner I (1991)

EX1118 - W.R. Noyes ACRO Ballot Information (2017)

EX1119 - W.R. Noyes About (CCND)

EX1120 - PDR Entry for Furosemide Injection (2000)

EX1123 - PDR Entry for Lantus (2001)

EX1126 - Levy (2019)

EX1127 - U.S. Patent 6,509,031 issued January 21, 2003

EX1130 - U.S. Patent 6,280,772 issued August 28, 2001

EX1131 - U.S. Patent 6,271,278 issued August 7, 2001

EX1132 - U.S. Patent 6,268,405 issued July 31, 2001

EX1134 - U.S. Patent 6,110,484 issued August 29, 2000

EX1133 - U.S. Patent 6,031,148 issued February 29, 2000

EX1135 - U.S. Patent 5,932,539 issued August 3, 1999

EX1138 - U.S. Patent 5,865,367 issued February 2, 1999

EX1140 - U.S. Patent 5,618,563 issued April 8, 1997

EX1142 - U.S. Patent 4,970,298 issued November 13, 1990

EX1145 - PCT Publication WO1993017669 published September 16, 1993

EX1136 - U.S. Patent 5,874,500 issued February 23, 1999

EX1137 - U.S. Patent 5,863,984 issued January 26, 1999

EX1139 - U.S. Patent 5,759,583 issued June 2, 1998

EX1141 - U.S. Patent 5,599,552 issued February 4, 1997

EX1143 - U.S. Patent 4,703,108 issued October 24, 1987

EX1144 - U.S. Patent 4,193,813 issued March 18, 1980

EX1146 - U.S. Patent 6,224,893 issued May 1, 2001

EX1147 - Nakayama & Matsuda (1992)

EX1148 - Lutolf (2001)

EX1149 - U.S. Patent Publication 2020-0009277 published January 9, 2020

EX1150 - Moon (2017)

EX1151 - Peach (2018)

Petitioner's Reply

Petitioner's Updated Exhibit List

Petitioner's Updated Exhibit List

Transcript of Conference Call w PTAB (October 28, 2020)

MODIFIED SCHEDULING ORDER

Order - Conduct of the Proceeding

Petitioner's email to PTAB Trials (October 21, 2020)

Petitioner's Mandatory Change-of-Information Notices

Petitioner's Power of Attorney

Notice of Deposition of Jessica Ray

Notice of Deposition of Timothy Showalter

Notice of Deposition of Gary Wnek

Petitioner's Objections to Evidence Submitted With Corrected Patent Owner Response

Ex. 2027 - Supplemental Declaration of Timothy N. Showalter, MD, MPH

Corrected Patent Owner Response

Ex. 2026 - Declaration of Jessica Ray

PANEL CHANGE ORDER Conduct of the Proceedings 37 C.F.R. ¿¿ 42.5

Petitioner's Objections to Evidence

Patent Owner Response

Ex. 2001 - Declaration of Timothy N. Showalter, M.D., Ph.D.

Ex. 2002 - Declaration of Gary E. Wnek, Ph.D.

Ex. 2003 - Balazs, The Physical Properties of Synovial Fluid (1974)

Ex. 2004 - Zimmerman, In Vivo Measurements of the Viscoelasticity (1980)

Ex. 2005 - Umehara et al, Effects of Degeneration on the Elastic Modulus Distribution (1996)

Ex. 2007 - Danehy and Parameswaran, Acidic Dissociation Constants of Thiols (1968)

Ex. 2010 - Mitchell, Alternative starting materials for industrial processes (1992)

Ex. 2014 - De Novo Classification Request for SpaceOAR System, FDA decision (2014)

Ex. 2016 - Babayan, Re Aminsharifi et al., Major Complications and Adverse Events (2020)

Ex. 2020 - Gay, Radiation Therapy for Prostate Cancer (2018)

Ex. 2021 - Noyes, Human Collagen Injections to Reduce Rectal Dose (2012)

Ex. 2022 - Prada et al, Transperineal Injection of Hyaluronic Acid in Anterior (2007)

Ex. 2006 - Silver and Christiansen, Biomaterials Science and Biocompatibility, Ch. 7 (1999)

Ex. 2008 - Bruskov et al., Heat-induced formation of reactive oxygen species (2002)

Ex. 2009 - Leonov and Elad, Light-induced free radical alkylation (1977)

Ex. 2011 - Rochette et al, UVA-induced cyclobutane pyrimidine dimers (2003)

Ex. 2012 - Boston Scientific Announces Agreement to Acquire Augmenix (press release 2018)

Ex. 2013 - Pieczonka et al, Hydrogel Spacer Application Technique (2016)

Ex. 2015 - Mariados et al, Hydrogel Spacer Prospective Multicenter Randomized (2015)

Ex. 2017 - Augmenix, Inc. Announces Medicare Administrative Contractor (Press Release 2017)

Ex. 2018 - Augmenix Announces Medicare Reimbursement Rates (Press Release 2017)

Ex. 2019 - Siegel, Cancer Statistics (2019)

Ex. 2023 - Rao, A Novel Absorbable Radiopaque Hydrogel Spacer (2017)

Ex. 2024 - Hepp et al. Case report use of a contrasted hydrogel spacer (2018)

Ex. 2025 - Hwang, Stereotactic body radiotherapy with periprostatic hydrogel (2019)

Order - Granting Petitioner's Motions to Submit Supplemental Information - 37 CFR 42.123(a)

Granting Petitioners Unopposed Motions for Pro Hac Vice Admission of Tung-On Kong 37 C.F.R. sec 42.10(c)

Petitioner's Updated Exhibit List

Joint Notice of Stipulation to Modify Schedule

Notice of Deposition of Adam Dicker

MODIFIED SCHEDULING ORDER 37 C.F.R. 42.5

Patent Owner Opposition to Motion for Supplemental Information

Petitioner's Updated Exhibit list

U.S. Patent No.: 7,247,324, O. Hnojewyj et al., Issued: July 24, 2007

A.P. Sclafani et al., ¿¿¿Autologous Collagen Dispersion (Autologen) as a Dermal Filler,¿¿¿ Arch. Facial Plast. Surg. 2:48-52 (2000)

Email from Patent Trial and Appeal Board issued May 8, 2020

Petitioner Palette Life Sciences, Inc. Motion for Supplemental Information

U.S. Patent No.: 5,410,016, J. Hubbell et al., Issued: April 25, 1995

Petitioner's Updated Exhibit List

Petitioner's Updated Exhibit List

Patent Owner Objections to Petition Evidence

Petitioner's Motion for Pro Hac Vice Admission

Petitioner's Updated Exhibit List

Tung-On Kong WSGR Bio

Declaration of Tung-On Kong

Trial Instituted Document

SCHEDULING ORDER

Patent Owner Preliminary Response

Patent Owner Mandatory Notices

Patent Owner Power of Attorney

Notice of Accord Filing Date

Petitioner's Power of Attorney

U.S. Patent No.: 8,257,723, W.R. Noyes, Issued: September 4, 2012

Curriculum Vitae of Dr. Adam Dicker

U.S. Provisional Application No.: 60/427,662, W.R. Noyes (filed: November 19, 2002)

U.S. Patent No.: 7,744,913, W.R. Noyes, Issued: June 29, 2010

Declaration of Dr. Adam Dicker, M.D., Ph.D. in Support of Petition for Inter Partes Review of U.S. Patent No. 8,257,723

File History of U.S. Patent No.: 8,257,723

File History of U.S. Patent No.: 7,744,913

U.S. Provisional Application No.: 60/391,027, W.R. Noyes (filed: June 24, 2002)

U.S. Provisional Application No.: 60/444,143, W.R. Noyes (filed: January 31, 2003)

U.S. Patent No.: 6,624,245, D.G. Wallace et al., Issued: September 23, 2003

A.B.S. Ball et al., ¿¿¿Silicone implant to prevent visceral damage during adjuvant radiotherapy for retroperitoneal sarcoma,¿¿¿ British Journal of Radiology 63:346-348 (May 1990)

J.P. Hoffman et al., ¿¿¿Use of saline-filled tissue expanders to protect the small bowel from radiation,¿¿¿ Oncology (Williston Park) 12(1):51-54 (January 1998) (¿¿¿Hoffman II¿¿¿)

B.D. Minsky et al., ¿¿¿Carcinoma of the esophagus. Part 1: Primary therapy,¿¿¿ Oncology (Williston Park) 13(9):1225-1236 (September 1999)

E.K. Reddy and C.M. Mansfield, ¿¿¿Carcinoma of the prostate,¿¿¿ in THERAPEUTIC RADIOLOGY: NEW DIRECTIONS IN THERAPY, Chapter 11 (Medical Examination Publishing Company, New Hyde Park, New York) (1983)

J.A. Del Regato, ¿¿¿Radiotherapy in the conservative treatment of operable and locally inoperable carcinoma of the prostate,¿¿¿ Radiology 88:761-766 (1967)

M.A. Bagshaw et al., ¿¿¿External beam radiation therapy of primary carcinoma of the prostate,¿¿¿ Cancer 36:723-728 (1975)

W.R. Lee et al, ¿¿¿Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a ...,¿¿¿ International Journal of Radiation Oncology: Biology Physics 46(1):83-88 (2000) (¿¿¿Lee II¿¿¿)

S.E.M. Langley and R. Laing, ¿¿¿Prostate brachytherapy has come of age: a review of the technique and results,¿¿¿ BJU International 89:241-249 (2002)

A. Dicker et al., ¿¿¿Introduction,¿¿¿ in BASIC AND ADVANCED TECHNIQUES IN PROSTATE BRACHYTHERAPY, Chapter 1 (eds. A. Dicker et al.) (CRC Press, Taylor & Francis, London and New York) (2005)

W.U. Shipley et al., ¿¿¿Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal ...,¿¿¿ International Journal of Radiation Oncology: Biology Physics 32(1):3-12 (April 1995)

G.H. Jordan et al., ¿¿¿Major rectal complications following interstitial implantation of 125iodine for carcinoma of the prostate,¿¿¿ The Journal of Urology 134(6):1212-1214 (December 1985)

Cherr et al., ¿¿¿Rectourethral fistula and massive rectal bleeding from iodine-125 prostate brachytherapy: a case report,¿¿¿ The American Surgeon 67(2):131-134 (February 2001)

L. Potters, ¿¿¿Rectal complications following permanent seed implants,¿¿¿ in BASIC AND ADVANCED TECHNIQUES IN PROSTATE BRACHYTHERAPY, Chapter 47 (CRC Press, Taylor & Francis, London and New York) (2005)

B.E. Waddell et al., ¿¿¿Absorbable mesh sling prevents radiation-induced bowel injury during ¿¿¿sandwich¿¿¿ chemoradiation for rectal cancer,¿¿¿ Archives of Surgery 135(10):1212-1217 (October 2000) (¿¿¿Waddell I¿¿¿)

M.A. Moerland et al., ¿¿¿Evaluation of permanent I-125 prostate implants using radiography and magnetic resonance imaging,¿¿¿ International Journal of Radiation Oncology: Biology Physics 37:927-933 (1997)

C.J. Johnston et al., ¿¿¿Radiation-induced pulmonary fibrosis: examination of chemokine and chemokine receptor families,¿¿¿ Radiation Research 157(3):256-265 (March 2002)

PCT Publication No.: WO 94/25080, L. Griffith-Cima et al. (published: November 10, 1994)

U.S. Patent No.: 6,375,634, R.G. Carroll, Issued: April 23, 2002

A. Jemal et al, ¿¿¿Cancer statistics, 2002,¿¿¿ CA: A Cancer Journal for Clinicians 52(1):23-47 (2002)

J.L. Warren et al., ¿¿¿Evaluation of trends in the cost of initial cancer treatment,¿¿¿ JNCI: Journal of the National Cancer Institute 100:888-897 (2008)

R. Sauer, ¿¿¿Adjuvant and neoadjuvant radiotherapy and concurrent radiochemotherapy for rectal cancer,¿¿¿ Pathology Oncology Research 8(1):7-17 (2002)

S.S. Yoon et al., ¿¿¿Surgical treatment and other regional treatments for colorectal cancer liver metastases,¿¿¿ The Oncologist 4(3):197-208 (1999)

L.F. Fajardo, ¿¿¿Morphology of radiation effects on normal tissues,¿¿¿ in PRINCIPLES AND PRACTICE OF RADIATION ONCOLOGY, Chapter 4 (eds. C.A. Perez and L.W. Brady) (Lippincott Company, Philadelphia) (3rd ed. 1998)

R.J. Berry, ¿¿¿Basic concepts in radiobiology: a review,¿¿¿ in THERAPEUTIC RADIOLOGY: NEW DIRECTIONS IN THERAPY, Chapter 1 (Medical Examination Publishing Company, New Hyde Park, New York) (1983)

D.C. Damin and A.R. Lazzaron, ¿¿¿Evolving treatment strategies for colorectal cancer: a critical review of current therapeutic options,¿¿¿ World Journal of Gastroenterology 20(4): 877-887 (January 28, 2014)

S.R. Denmeade and J.T. Isaacs, ¿¿¿A history of prostate cancer treatment,¿¿¿ Nature Reviews Cancer 2:389-396 (May 2002)

P. Wust et al., ¿¿¿Hyperthermia in combined treatment of cancer,¿¿¿ Lancet Oncology 3(8):487-497 (August 2002)

F.W. George et al., ¿¿¿Cobalt-60 telecurietherapy in the definitive treatment of carcinoma of the prostate: a preliminary report,¿¿¿ Journal of Urology 93:102-109 (January 1965)

M.A. Bagshaw et al., ¿¿¿Linear accelerator supervoltage radiotherapy: VII. carcinoma of the prostate,¿¿¿ Radiology 85:121-129 (1965)

W.R. Lee et al., ¿¿¿Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal ...,¿¿¿ International Journal of Radiation Oncology: Biology Physics 35(2):251-257 (May 1996) (¿¿¿Lee I¿¿¿)

D. Kuban et al., ¿¿¿Hazards of dose escalation in prostate cancer radiotherapy,¿¿¿ International Journal of Radiation Oncology: Biology Physics 57(5):1260-1268 (December 2003)

J.P. Hoffman et al., ¿¿¿Morbidity after intraperitoneal insertion of saline-filled tissue expanders for small bowel exclusion from radiotherapy treatment fields:...,¿¿¿ The American Surgeon 60(7):473-483 (July 1994) (¿¿¿Hoffman I¿¿¿)

U.S. Patent No.: 6,206,930, K.J.L. Burg et al., Issued: March 27, 2001

B. Emami et al., ¿¿¿Tolerance of normal tissue to therapeutic irradiation,¿¿¿ International Journal of Radiation Oncology: Biology Physics 21:109-122 (1991)

S. M. Tadavarthy et al., ¿¿¿Polyvinyl alcohol (Ivalon)--a new embolic material,¿¿¿ American Journal of Roentgenology 125:609-616 (1975)

S. K¿¿nemann et al., ¿¿¿Fractionated perioperative high dose rate brachytherapy using a tissue equivalent bendy applicator,¿¿¿ British Journal of Radiology 75:453-459 (2002)

G.J. D¿¿¿Angio et al., ¿¿¿Protection of certain structures from high doses of irradiation,¿¿¿ American Journal of Roentgenology 122:103-108 (1974)

K.B. Clough et al., ¿¿¿Laparoscopic unilateral ovarian transposition prior to irradiation: prospective study of 20 cases,¿¿¿ Cancer 77:2638-2645 (1996)

U.S. Patent No.: 6,210,314, M. Ein-Gal, Issued: April 3, 2001

G.C. Bentel , ¿¿¿Treatment Planning ¿¿¿ Pelvis¿¿¿ in RADIATION THERAPY PLANNING, Chapter 13 (ed. G.C. Bentel) (McGraw Hill) (2nd ed. 1996)

C. Kettle and R.B. Johanson, ¿¿¿Absorbable synthetic versus catgut suture material for perineal repair,¿¿¿ Cochrane Database of Systematic Reviews 2: CD000006 (2000)

U.S. Patent No.: 6,066,856, S.J. Fishman, Issued: May 23, 2000

U.S. Patent No.: 5,922,025, W.G. Hubbard, Issued: July 13, 1999

U.S. Patent No.: 6,635,267, T. Miyoshi et al., Issued: October 21, 2003

U.S. Patent No.: 6,723,709, D. Pressato et al., Issued: April 20, 2004

U.S. Patent No.: 6,129,761, J.A. Hubbell, Issued: October 10, 2000

B.E. Waddell et al., ¿¿¿Prevention of chronic radiation enteritis,¿¿¿ Journal of the American College of Surgeons 189:611-624 (1999) (¿¿¿Waddell II¿¿¿)

F.M. Khan, ¿¿¿Dose distribution and scatter analysis,¿¿¿ in THE PHYSICS OF RADIATION THERAPY, Chapter 9 (ed. W.M. Passano III) (Williams & Wilkins) (2nd ed., 1994)

M. Kennedy et al., ¿¿¿Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C,¿¿¿ The American Journal of Gastroenterology 96:1080-1084 (2001)

L. Portelance et al., ¿¿¿Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer...,¿¿¿ International Journal of Radiation Oncology: Biology Physics 51:261-266 (2001)

U.S. Patent No.: 4,674,488, A.S. Nashef and T.D. Campbell, Issued: June 23, 1987

U.S. Patent No.: 4,706,652, B.S. Horowitz, Issued: November 17, 1987

Petitioner¿¿¿s Explanation of Multiple Petitions Challenging Patent No. 8,257,723 and Ranking of Petitions

Petition for Inter Partes Review